High-energy proton experiments optimize production of medical imaging isotopes while providing insight into how to protect astronauts from space radiation.
University researchers produce a novel method of shipping the promising medical isotope Astatine-211
NextGen power sources may satisfy the need for long-term, compact power for use in remote or extreme environments.
Promising study details how radioactive agents could be sent directly to cancer cells.
New production methods for cerium-134 advance technologies for imaging human disease and guiding treatment.
A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
New system makes it easier to produce isotopes for radiopharmaceutical therapy.
A new supply of a critical radioisotope advances personalized medicine.
Innovative technology improves isotope production yields and enhances capabilities for advanced research on new isotopes for medical applications.
Production of actinium-227 ramps up for use in a drug to fight prostate cancer that has spread to bone.
New method produces high-purity zirconium-89, a diagnostic radionuclide used to image cancerous tumors.
Laboratory automation applied to complex radiochemical isolation of astatine-211 from cyclotron-bombarded targets.
